Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 5/20 | 0.41 |
| ▸ | NPY4R | P50391 | 10/20 | 0.40 |
| ▸ | NPY1R | P25929 | 7/20 | 0.40 |
| ▸ | NPY2R | P49146 | 5/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.39 |
| ▸ | NMT2 | O60551 | 1/20 | 0.38 |
| ▸ | NMT1 | P30419 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29636352 | 0.98 | NOD1 (0.42) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29636367 | 0.93 | NPY4R (0.48) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29636369 | 0.93 | NPY4R (0.44) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29870738 | 0.91 | NOD1 (0.46) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29636351 | 0.90 | NPY4R (0.44) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29636356 | 0.90 | NPY4R (0.48) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL3074240 | 0.90 | NPY4R (0.48) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL3074247 | 0.90 | NPY4R (0.48) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30839890 | 0.89 | NPY4R (0.42) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL16189773 | 0.88 | SIRT5 (0.43) | FURINNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3187508-B1 | LYSOSOMAL TARGETING PEPTIDES AND USES THEREOF | BIOMARIN PHARM INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20230241187-A1 | Lysosomal Targeting Peptides and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | 2023-08-03 | — | — | US | disclosed |
| US-20220354934-A1 | Lysosomal Targeting Peptides and Uses Thereof | BIOMARIN PHARMACEUTICAL INC. | 2022-11-10 | — | — | US | disclosed |
| US-11351231-B2 | Lysosomal targeting peptides and uses thereof | BIOMARIN PHARMACEUTICAL INC. (US) | 2022-06-07 | — | — | US | disclosed |